260 related articles for article (PubMed ID: 30211824)
41. The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice.
Li PC; Liu LF; Jou MJ; Wang HK
BMC Neurosci; 2016 Jun; 17(1):37. PubMed ID: 27296974
[TBL] [Abstract][Full Text] [Related]
42. Delayed administration of the GLP-1 receptor agonist liraglutide improves metabolic and functional recovery after cerebral ischemia in rats.
Dong W; Miao Y; Chen A; Cheng M; Ye X; Song F; Zheng G
Neurosci Lett; 2017 Feb; 641():1-7. PubMed ID: 28122257
[TBL] [Abstract][Full Text] [Related]
43. The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-/-) mouse model.
Gaspari T; Welungoda I; Widdop RE; Simpson RW; Dear AE
Diab Vasc Dis Res; 2013 Jul; 10(4):353-60. PubMed ID: 23673376
[TBL] [Abstract][Full Text] [Related]
44. L-dopa-Dependent Effects of GLP-1R Agonists on the Survival of Dopaminergic Cells Transplanted into a Rat Model of Parkinson Disease.
Elabi OF; Davies JS; Lane EL
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830228
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
Mulvihill EE; Varin EM; Ussher JR; Campbell JE; Bang KW; Abdullah T; Baggio LL; Drucker DJ
Diabetes; 2016 Mar; 65(3):742-54. PubMed ID: 26672095
[TBL] [Abstract][Full Text] [Related]
46. The impact of the glucagon-like peptide 1 receptor agonist liraglutide on the streptozotocin-induced diabetic mouse kidney proteome.
Liljedahl L; Pedersen MH; McGuire JN; James P
Physiol Rep; 2019 Feb; 7(4):e13994. PubMed ID: 30806030
[TBL] [Abstract][Full Text] [Related]
47. GLP-1 receptor agonist ameliorates experimental lung fibrosis.
Fandiño J; Toba L; González-Matías LC; Diz-Chaves Y; Mallo F
Sci Rep; 2020 Oct; 10(1):18091. PubMed ID: 33093510
[TBL] [Abstract][Full Text] [Related]
48. Glucagon-like peptide 1 receptor agonist ameliorates the insulin resistance function of islet β cells via the activation of PDX-1/JAK signaling transduction in C57/BL6 mice with high-fat diet-induced diabetes.
Hao T; Zhang H; Li S; Tian H
Int J Mol Med; 2017 Apr; 39(4):1029-1036. PubMed ID: 28290604
[TBL] [Abstract][Full Text] [Related]
49. Liraglutide Promotes the Osteogenic Differentiation in MC3T3-E1 Cells via Regulating the Expression of Smad2/3 Through PI3K/Akt and Wnt/β-Catenin Pathways.
Gao L; Li SL; Li YK
DNA Cell Biol; 2018 Dec; 37(12):1031-1043. PubMed ID: 30403540
[TBL] [Abstract][Full Text] [Related]
50. Lack of effect of prolonged treatment with liraglutide on cardiac remodeling in rats after acute myocardial infarction.
Kyhl K; Lønborg J; Hartmann B; Kissow H; Poulsen SS; Ali HE; Kjær A; Dela F; Engstrøm T; Treiman M
Peptides; 2017 Jul; 93():1-12. PubMed ID: 28460895
[TBL] [Abstract][Full Text] [Related]
51. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.
Nauck MA; Meier JJ; Cavender MA; Abd El Aziz M; Drucker DJ
Circulation; 2017 Aug; 136(9):849-870. PubMed ID: 28847797
[TBL] [Abstract][Full Text] [Related]
52. The effect of thymectomy on tolerance induction and cardiac allograft vasculopathy in a miniature swine heart/kidney transplantation model.
Yamada K; Choo JK; Allan JS; Erhorn AE; Menard MT; Mawulawde K; Slisz JK; Aretz HT; Shimizu A; Sachs DH; Madsen JC
Transplantation; 1999 Aug; 68(4):485-91. PubMed ID: 10480404
[TBL] [Abstract][Full Text] [Related]
53. Combined therapy of mesenchymal stem cells with a GLP-1 receptor agonist, liraglutide, on an inflammatory-mediated diabetic non-human primate model.
Navabi R; Negahdari B; Hajizadeh-Saffar E; Hajinasrollah M; Jenab Y; Rabbani S; Pakzad M; Hassani SN; Hezavehei M; Jafari-Atrabi M; Tahamtani Y; Baharvand H
Life Sci; 2021 Jul; 276():119374. PubMed ID: 33745896
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory effects of glucagon-like peptide-1 receptor on epilepsy.
Wen Y; Wu K; Xie Y; Dan W; Zhan Y; Shi Q
Biochem Biophys Res Commun; 2019 Mar; 511(1):79-86. PubMed ID: 30770099
[TBL] [Abstract][Full Text] [Related]
55. Plaque-targeted, proteolysis-resistant, activatable and MRI-visible nano-GLP-1 receptor agonist targets smooth muscle cell differentiation in atherosclerosis.
Maiseyeu A; Di L; Ravodina A; Barajas-Espinosa A; Sakamoto A; Chaplin A; Zhong J; Gao H; Mignery M; Narula N; Finn AV; Rajagopalan S
Theranostics; 2022; 12(6):2741-2757. PubMed ID: 35401813
[No Abstract] [Full Text] [Related]
56. A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
Yuan Z; Li D; Feng P; Xue G; Ji C; Li G; Hölscher C
Eur J Pharmacol; 2017 Oct; 812():82-90. PubMed ID: 28666800
[TBL] [Abstract][Full Text] [Related]
57. The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution.
Zhao L; Zhu C; Lu M; Chen C; Nie X; Abudukerimu B; Zhang K; Ning Z; Chen Y; Cheng J; Xia F; Wang N; Jensen MD; Lu Y
J Endocrinol; 2019 Feb; 240(2):271-286. PubMed ID: 30530905
[TBL] [Abstract][Full Text] [Related]
58. Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis.
Kojima M; Takahashi H; Kuwashiro T; Tanaka K; Mori H; Ozaki I; Kitajima Y; Matsuda Y; Ashida K; Eguchi Y; Anzai K
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785012
[TBL] [Abstract][Full Text] [Related]
59. GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1β-induced metabolic disturbance and mitochondrial dysfunction.
Zhang L; Tian J; Diao S; Zhang G; Xiao M; Chang D
Chem Biol Interact; 2020 Dec; 332():109252. PubMed ID: 32898504
[TBL] [Abstract][Full Text] [Related]
60. Liraglutide Improves Renal Endothelial Function in Obese Zucker Rats on a High-Salt Diet.
Sukumaran V; Tsuchimochi H; Sonobe T; Shirai M; Pearson JT
J Pharmacol Exp Ther; 2019 Jun; 369(3):375-388. PubMed ID: 30910920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
